Peter Salzmann
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Peter Salzmann
Peter Salzmann was last confirmed as Board Member at Corbus Pharmaceuticals Holdings, Inc. (CRBP) in a filing dated April 2, 2024. Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed May 20, 2024 that Peter Salzmann was appointed director, effective May 16, 2024.
“The election of each of Yuval Cohen, Alan Holmer, Avery W. Catlin, Rachelle Jacques, John Jenkins, Peter Salzmann, Anne Altmeyer and Yong Ben as directors to hold office for a term of one year, until his or her successor is duly elected and qualified or he or she is otherwise unable to complete his or her term.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-01-01–2024-04-02
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.